Novartis announced FDA approval for Fabhalta
Go back to Novartis announced FDA approval for Fabhalta| NOVARTIS AG (NYSE: NVS) | Delayed: 137.48 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $137.48 | 52 Week High | $89.15 | |||
| Open | $137.48 | 52 Week Low | $69.84 | |||
| Day High | $137.48 | P/E | N/A | |||
| Day Low | $137.48 | EPS | $0.00 | |||
| Volume | 46,580 | |||||

